HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings.

AbstractOBJECTIVE:
To evaluate a management protocol of fetal supraventricular tachycardia (SVT) based on prior identification of the underlying mechanism.
DESIGN AND SETTING:
Prospective study in a mother-child tertiary university centre.
PATIENTS:
During a consecutive 36 month period, 18 fetuses with sustained SVT underwent a superior vena cava/ascending aorta (SVC/AA) Doppler investigation in an attempt to determine the atrioventricular (AV) relation and to treat the arrhythmia according to a pre-established management protocol.
MAIN OUTCOME MEASURE:
Rate of conversion to sinus rhythm.
RESULTS:
Seven fetuses had short ventriculoatrial tachycardia, five of these with a 1:1 AV conduction suggesting re-entrant tachycardia. The first choice drug was digoxin and all were converted. One fetus had AV dissociation leading to the diagnosis of junctional ectopic tachycardia, which was resistant to digoxin and sotalol; amiodarone achieved postnatal conversion. One fetus had SVT and first or second AV block; the diagnosis was atrial ectopic tachycardia (AET), which responded to sotalol given as a drug of first choice. Seven fetuses had long ventriculoatrial tachycardia: one with sinus tachycardia (no treatment), one with permanent junctional reciprocating tachycardia (PJRT), and three with AET. The first choice drug was sotalol and all were converted. One AET was classified postnatally as PJRT. Six fetuses had intra-atrial re-entrant tachycardia: five with 2:1 AV conduction and one with variable block. The first choice drug was digoxin. Conversion was achieved in all but one, who died after birth from advanced cardiomyopathy.
CONCLUSION:
The electrophysiological mechanisms of fetal SVT can be clarified with SVC/AA Doppler. The proposed management protocol has so far yielded a good rate of conversion to sinus rhythm.
AuthorsJ-C Fouron, A Fournier, F Proulx, J Lamarche, J L Bigras, C Boutin, M Brassard, S Gamache
JournalHeart (British Cardiac Society) (Heart) Vol. 89 Issue 10 Pg. 1211-6 (Oct 2003) ISSN: 1468-201X [Electronic] England
PMID12975422 (Publication Type: Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
Topics
  • Anti-Arrhythmia Agents (therapeutic use)
  • Blood Flow Velocity
  • Echocardiography, Doppler (methods)
  • Echocardiography, Doppler, Pulsed (methods)
  • Female
  • Fetal Diseases (diagnostic imaging, drug therapy, physiopathology)
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Postnatal Care
  • Pregnancy
  • Prenatal Care (methods)
  • Prospective Studies
  • Tachycardia, Supraventricular (diagnostic imaging, drug therapy, physiopathology)
  • Treatment Outcome
  • Ultrasonography, Prenatal (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: